Report Examines PEPFAR Transition in South Africa
January 16, 2014
Health GAP and its partners on Wednesday released a report that "looks at the PEPFAR 'transition' in [South Africa] -- moving from 'directly supporting' over one million people on ARV treatment in South Africa in early 2011 to a near complete withdrawal from support for 'direct services.' ... The report finds that the political transition -- toward increased South African ownership and innovative models of shared governance for U.S. funds -- is yielding important benefits ... [and] recommends an urgent course correction for PEPFAR South Africa -- tracing patients and health workers while considering a more measured approach in the country," according to press release. The report accompanies an article forthcoming in the Journal of Acquired Immune Deficiency Syndromes (1/15).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)